Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yoshiki Kuwabara
Observed name:
YOSHIKI KUWABARA
Institutions:
Saitama Medical Center, Saitama Medical University,
Saitama Medical University
Observed institutions:
Social Insurance Saitama Chuo Hospital,
Saitama Medical Center, Saitama Medical University,
Saitama Medical University
ORCID:
0009-0009-7036-0021
Observed ORCID:
0009-0009-7036-0021
OpenAlex ID:
A5025465192
Functional inhibition of heat shock protein 70 by VER ‐155008 suppresses pleural mesothelioma cell proliferation via an autophagy mechanism
2020
·
Kosuke Sakai
, Maya Inoue
, et al.
·
Thoracic Cancer
·
21
PDF
Vascular Ehlers-Danlos Syndrome with a Novel Missense Mutation in COL3A1: A Man in His 50s with Aortic Dissection after Interventional Treatment for Hemothorax as the First Manifestation
2019
·
Kosuke Sakai
, Maiko Toda
, et al.
·
Internal Medicine
·
15
PDF
Validation of prognostic impact of number of extrathoracic metastases according to the eighth TNM classification: a single-institution retrospective study in Japan
2019
·
Kosuke Sakai
, Joji Kuramoto
, et al.
·
International Journal of Clinical Oncology
·
5
Effects of Autophagy Inhibition by SAR405 , a Selective VPS34 Inhibitor, on Pleural Mesothelioma Cells
2026
·
Yoshiki Kuwabara
, Kosuke Sakai
, et al.
·
Thoracic Cancer
·
3
Association of Immune‐Related Adverse Events and the Efficacy of Immune Checkpoint Inhibitors in Non‐Small Cell Lung Cancer: Adjusting for Immortal Time Bias
2026
·
Yoshiki Kuwabara
, Hiroyuki Ohya
, et al.
·
Thoracic Cancer
·
2
Erlotinib-Induced Ocular Cicatricial Pemphigoid in EGFR-Mutated Non–Small Cell Lung Cancer: A Case Report
2026
·
Yumiko Ogawa-Kobayashi
, Itsuka Matsumoto
, et al.
·
Clinical Lung Cancer
·
1
Efficacy of osimertinib resumption with dabrafenib and trametinib for elderly patients with EGFR-mutated lung adenocarcinoma harboring acquired BRAF V600E resistant mutation resistant to osimertinib
2025
·
Yusuke Hirata
, Nobuyuki Koyama
, et al.
·
Japanese Journal of Clinical Oncology
·
1
Abstract 4711: Evaluation of effect of autophagy inhibition by SAR405, a selective Vps34 inhibitor, on proliferation of pleural mesothelioma cells
2024
·
Yoshiki Kuwabara
, Kosuke Sakai
, et al.
·
Cancer Research
·
1
Impact of Locoregional Therapies for Brain Lesions on Survival in Patients With Non-small Cell Lung Cancer With Multiple Extrathoracic Metastases
2023
·
KOSUKE SAKAI
, JOJI KURAMOTO
, et al.
·
Anticancer Research
·
1
PDF
Initial rapidity of tumor growth as a prognostic factor for the therapeutic effect of immune-checkpoint inhibitors in patients with non-small cell lung cancer: evaluation for linear and non-linear correlation
2021
·
Kosuke Sakai
, Joji Kuramoto
, et al.
·
Journal of Thoracic Disease
·
1
PDF
Efficacy of Immune Checkpoint Inhibitors in Combination With Platinum‐Based Doublet Chemotherapy for Extensive‐Stage Small‐Cell Lung Cancer Patients With Eastern Cooperative Oncology Group‐Performance Status 2–3: A Single‐Institution Retrospective Study
2025
·
Kosuke Sakai
, Shigeru Ishii
, et al.
·
Cancer Medicine
PDF
Abstract 1830: Evaluation of anti-tumor effects of VER-155008, a functional inhibitor of HSP70, through macroautophagy in mesothelioma cells
2020
·
Kosuke Sakai
, Maya Inoue
, et al.
·
Cancer Research
Show more works
View as search
Works count:
12
Citation count:
51
H-index:
3
I10-index:
2
Year
Topic
Type